The Valley Desk

NCT03847428 · Interventional trial

Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment

Overall registry status Completed

Phase 3

Conditions Hepatocellular Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov